All News IPH Limited

Equities

Delayed Australian S.E. Other stock markets 04:29:09 03/05/2024 BST			5-day change	1st Jan Change
6.14 ^AUD	+0.16%		-1.05%	-4.13%

02-29	IPH Limited Announces Executive Changes	CI
02-28	IPH Managing Director Pares Shareholding in Firm	MT

IPH Limited Announces Executive Changes	02-29	CI
IPH Managing Director Pares Shareholding in Firm	02-28	MT
Transcript : IPH Limited, H1 2024 Earnings Call, Feb 22, 2024	02-21
IPH Reports H1 FY24 Revenue Up 22%, EPS of AU$0.0879	02-21	MT
IPH Ltd. Reports H1 FY24 Revenue Up 21% to AU$274.4 Million; Underlying Diluted EPS of AU$0.212	02-21	MT
IPH Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-21	CI
US FDA Ends Partial Clinical Hold on Innate Pharma's Investigational Cancer Drug	01-04	MT
Sanofi Licenses Natural Killer Cell Engager Program from Innate Pharma	12-19	MT
IPH Completes ROBIC Business Acquisition	12-18	MT
IPH Limited completed the acquisition of ROBIC L.L.P.	12-14	CI
IPH Announces Third Canadian Acquisition with AU$124 Million Deal	11-22	MT
IPH Managing Director and CEO Sells Company Shares	11-22	MT
IPH Limited entered into an agreement to acquire ROBIC L.L.P. for CAD 110 million.	11-19	CI
IPH Limited Approves Election of Director, David Wiadrowski	11-15	CI
IPH Limited Seeks Acquisitions	11-14	CI
Transcript : IPH Limited - Shareholder/Analyst Call	11-14
IPH Completes AU$75 Million Acquisition of Canadian IP Services Firm	02/10/23	MT
Australia Inc roiled by string of cyber attacks since late 2022	29/09/23	RE
IPH's Net Profit Jumps 23% in Fiscal Year 2023; Shares Rally 10%	17/08/23	MT
IPH Limited Seeks Acquisitions	17/08/23	CI

No results for this search